The National Comprehensive Cancer Network (NCCN) Oncology Research Program (OPR) will support a Phase II randomized trial for lung cancer patients titled TH-138. Joseph Treat, MD, Professor, Department of Hematology/Oncology, Fox Chase Cancer Center will serve as...
World-renowned experts on blood cancers are meeting in San Francisco on September 27-28 to help clinicians stay up-to-date on new, practice changing strategies to manage patients with hematologic malignancies at the NCCN 2019 Annual Congress: Hematologic Malignancies™...
P&T Community reports that the National Comprehensive Cancer Network (NCCN) Oncology Research Program has awarded grants to three clinical investigators from NCCN member institutions through a collaborative scientific research relationship with Taiho Oncology,...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
